H.R. 796: Second Chance for Moms Act

H.R. 796 is a federal bill in the 119th Congress. Currently, the drug mifepristone is labeled with information approved by the Food and Drug Administration (FDA) for its use in ending pregnancies. This bill mandates that the FDA update the labeling to include specific information about the hormone… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.